In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis.
Here we investigated the possibility to develop different levels of correlation between in vitro drug release profiles and in vivo pharmacokinetic parameters for three Buserelin implant formulations. The in vitro and in vivo data were analyzed using model-independent and model-dependent methods. Since diffusion, dissolution and erosion effects influence drug release in most cases a simple kinetic model is unlikely to explain the overall in vivo release behavior. Thus the in vitro drug release curves were analyzed according to the theoretical models of Higuchi and Korsmeyer-Peppas. For the formulation with predominant diffusion controlled release level A IVIVC could be established (R2=0.986). Independent on drug release mechanism, a level B correlation between the mean in vitro dissolution time (MDT) and mean in vivo residence time (MRT) was obtained with a correlation coefficient of 0.983. Finally, level C correlation were observed when single in vitro parameters, e.g. T50% (time required to release 50% of drug in vitro) where compared with single in vivo parameters like AUC. This study suggests that a level B correlation could be achieved even when drug release occurs by a combination of diffusion and erosion processes. More sophisticated in vitro models mimicking drug release under in vivo conditions are clearly desirable for parenteral depot formulations.
Schliecker
Gesine
G
Department of Pharmaceutics and Biopharmacy, Philipps University of Marburg, Ketzerbach 63, D-35032 Marburg, Lahn, Germany.
Schmidt
Carsten
C
Fuchs
Stefan
S
Ehinger
Andreas
A
Sandow
Jürgen
J
Kissel
Thomas
T
D020341:Absorbable Implants; D000818:Animals; D019540:Area Under Curve; D002064:Buserelin / Q000493:pharmacokinetics*; D002626:Chemistry, Pharmaceutical; D004285:Dogs; D008297:Male; D015233:Models, Statistical
D002064:Buserelin